Other studies have revealed that pioglitazone reduces intracellular Aβ in the CA1 region, decreases soluble Aβ and downregulates Apoe and Apba2 expression, involved in lipid shuttling and Aß processing, in 3xTg-AD mice [116]. Here, APBA2 is linked to Alzheimer disease.